The selection and use of agents that will accomplish all four of these actions, required by USP 800 and 797, continues to be a point of controversy and confusion. This roundtable is to separate fact from fiction, provide some rational suggestions and options, and answer questions and address the concerns of home infusion providers regarding these topics. Additionally, means of evaluating the effectiveness of these activities will be discussed.
Learning Objectives:
Describe the pros and cons of various potential DDCD agents.
Develop a DDCD program suitable for the attendee's situation.
Describe ways of testing the effectiveness of DDCD programs.